Results 121 to 130 of about 186,086 (280)
PLoS Pathogens, 2017 Successful treatment of aspergillosis caused by Aspergillus fumigatus is threatened by an increasing incidence of drug resistance. This situation is further complicated by the finding that strains resistant to azoles, the major antifungal drugs for ...
Daisuke Hagiwara +13 more
semanticscholar +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Both pulmonary tuberculosis (PTB) and coronavirus disease‐2019 (COVID‐19) are risk factors for chronic pulmonary aspergillosis (CPA) and other pulmonary infectious diseases because of residual lung damage. We report a case of Achromobacter spp. infection following CPA in an immunocompetent woman with a history of PTB and COVID‐19.
Marius Paulin Ngouanom Kuate +2 more
wiley +1 more source
Clinical and Translational Allergy, Volume 15, Issue 10, October 2025.ABSTRACT Background European guidelines recommend using a standardized baseline series of skin prick test (SPT) allergens for the diagnosis of airway allergies. In addition, local adaptation and/or extension of test panels according to regional exposure and sensitization patterns are increasingly being discussed.
Caroline Beutner +5 more
wiley +1 more source
Distribution of trypacidin in cultures of Aspergillus fumigatus [PDF]
, 1968 George F. Parker, P C Jenner
openalex +1 more source
Msphere, 2017 Tackling the multifactorial nature of virulence and antifungal drug resistance in A. fumigatus requires the mechanistic interrogation of a multitude of genes, sometimes across multiple genetic backgrounds. Classical fungal gene replacement systems can be
Q. Al Abdallah, Wenbo Ge, J. Fortwendel
semanticscholar +1 more source
eJHaem, Volume 6, Issue 5, October 2025.ABSTRACT Introduction Invasive fungal infection (IFI) after chimeric antigen receptor (CAR) T‐cell therapy is less common than bacterial and viral infections, but can be fatal once it develops. As most cases occur within 30 days after CAR T‐cell infusion, late‐onset IFI—particularly mould infection—appears to be under‐recognised.
Daisuke Ikeda +16 more
wiley +1 more source
Drug susceptibility of Aspergillus flavus and A.fumigatus to Itraconazole and Amphotericin B
مجله دانشگاه علوم پزشکی گرگان, 2013 Background and Objective: Aspergillosis is the most current causative agent of exogenous fungal nosocomial infection. This study was done to evaluate the drug susceptibility of Aspergillus flavus and A.fumigatus to itraconazole and amphotericin B ...
Kazemi A +3 more
doaj
Aspergillus fumigatus-Related Species in Clinical Practice
Frontiers in Microbiology, 2016 Aspergillus fumigatus is the main etiologic agent of invasive aspergillosis (IA). Other Aspergillus species belonging to the section Fumigati (A. fumigatus complex) may occasionally be the cause of IA.
Frederic eLamoth
doaj +1 more source
The Incorporation of [2-14C,4R-3H1]Mevalonate and [2-14C,4S-3H1]Mevalonate into Squalene, Ubiquinone and Ergosterol of Aspergillus fumigatus Fresenius [PDF]
, 1965 K. J. Stone, F. W. Hemming
openalex +1 more source
Fundamental &Clinical Pharmacology, Volume 39, Issue 5, October 2025.ABSTRACT This review highlights the integration of drug repurposing and nanotechnology‐driven delivery strategies as innovative approaches to enhance the antifungal activity of statins against mucosal candidiasis, providing a framework for future translational research and clinical application.
Dominique Mesquita e Silva +8 more
wiley +1 more source